At this year’s @Asembia Specialty Pharmacy Summit, BridgeBio will be supporting a satellite symposium with ReachMD to provide educational tools for navigating the evolving landscape in ATTR-CM. Register here: bit.ly/43Sknot

At the World Orphan Drug Congress Congress this week, Douglas Sproule M.D., M.Sc., CMO of our limb-girdle muscular dystrophy type 2I/R9 (LGMD2I/R9) program will be on a panel to discuss how to facilitate drug development in rare diseases. bit.ly/3W21pKi

This week at the World Orphan Drug Congress Congress, Sun-Gou Ji, Ph.D., BridgeBio’s VP of computational genomics will be presenting, about the benefits of leveraging genetic testing data to accelerate drug discovery for rare diseases. Learn more: bit.ly/3W21pKi

Our team will be at the International Congress of Myology Conference to present our novel bioassay measurement for alpha-dystroglycan, including Phase 2 and natural history data for our limb-girdle muscular dystrophy type 2I/R9 (LGMD2I / R9) program. bit.ly/43Z2CUx

Join us at the @AMCPorg Annual Meeting this year to hear about the ATTR therapeutic landscape through a BridgeBio supported satellite symposium with ReachMD. Register and learn more here: bit.ly/3vZhuFE

We're grateful for the opportunity at #ACC24 to meet with leaders in cardiology and discuss updates for heart conditions like ATTR-CM. This year, we shared data from the cardiac magnetic resonance substudy of ATTRibute-CM, our Phase 3 clinical trial for ATTR-CM.

We are thrilled to be supporting a live Symposium with Medscape and leading cardiologists onsite at #ACC24 on the evolving advancements of ATTR-CM. Register here to attend the panel discussion and Q&A live or virtually: bit.ly/3PtMJzg

For this year’s Light the Night, we gifted BridgeBio colleagues with red lightbulbs in hopes of spreading awareness around #AmyloidosisAwarenessMonth and the condition’s vast unmet need. Join us in the cause: bit.ly/3IbZrPR

Today, at the @EventsWCS Genomics of Rare Disease Conference, Sun-Gou Ji, Ph.D., our VP of computational genomics will present a genotype-first approach used to interrogate the allelic series of variants in the calcium sensing receptor associated with ADH1.bit.ly/4cAFr71